Journal
MOLECULAR MEDICINE
Volume 17, Issue 7-8, Pages 771-779Publisher
SPRINGER
DOI: 10.2119/molmed.2010.00091
Keywords
-
Funding
- National Science Council of Taiwan [NSC 98-2314-B-037-016-MY3, NSC 98-2314-B-037-017-MY3]
Ask authors/readers for more resources
Diabetes mellitus is characterized by elevated plasma glucose and increased rates of skin infections. Altered immune responses have been suggested to contribute to this prevalent complication, which involves microbial invasion. In this study we explored the effects of a high-glucose environment on the innate immunity of keratinocytes by focusing on beta defensin-3 (BD3) using in vivo and in vitro models. Our results demonstrated that the perilesional skins of diabetic rats failed to show enhanced BD3 expression after wounding. In addition, high-glucose treatment reduced human BD3 (hBD3) expression of cultured human keratinocytes. This pathogenic process involved inhibition of p38MAPK signaling, an event that resulted from increased formation of advanced glycation end products. On the other hand, toll-like receptor-2 expression and function of cultured keratinocytes were not significantly affected by high-glucose treatment. In summary, high-glucose conditions inhibited the BD3 expression of epidermal keratinocytes, which in turn contributed to the frequent occurrences of infection associated with diabetic wounding. (C) 2011 The Feinstein Institute for Medical Research, www.feinsteininstitute.org
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available